The HARMONY Alliance is using Big Data to develop more personalized treatments for blood cancer patients. This is a team effort involving hospitals, academic institutions, pharmaceutical companies, regulatory agencies, and patient organizations.
In our BigDataForBloodCancer awareness campaigns we engage with a broad audience to explain what Big Data can mean for the lives of patients and for the daily work of doctors in the clinic. In addition, we organized the 'World Big Data for Blood Cancer Awareness Day' on 30 September.
Read more at our dedicated web pages: www.bigdataforbloodcancer.eu
The HARMONY Alliance is a unique collaboration in blood cancer research and consist of approx. 100 organizations, with up to 400 HARMONY Ambassadors spread over Europe and other continents. Connect with us:
Find below a collection of the social media posts we shared to support World Cancer Day 2022:
#WorldCancerDay #bigdataforbloodcancer #CloseTheCareGap >> With 100,000+ patient data sets identified we are fully equipped to facilitate state-of-the-art research into blood cancers >> to improve the care for #bloodcancer #patients. Learn more: www.bigdataforbloodcancer.eu
#WorldCancerDay >> bigdataforbloodcancer.eu >> We are a partnership for #bigdata in #bloodcancer - involving patient partners to ensure that results of our #research matter to patients.
Acute Leukemia Advocates Network (ALAN); Child Cancer International (CCI) Europe; CLL Advocates Network; CML Advocates Network; Lymphoma Coalition; Myeloma Patients Europe; MDS Alliance; MPN Advocates Network; LeukaNet.
#WorldCancerDay >> #Closethecaregap >> We are a European consortium for #bigdata in #bloodcancer >> 100+ partners from 18 European countries to conduct #research/multi-stakeholder activities across 14 #bloodcancers. Funders: @IHIEurope @EFPIA @HorizonEU >> www.bigdataforbloodcancer.eu
Standing by #cancer #patients >> #WorldCancerDay >> our HARMONY Patient Cluster combine years of expertise in patient-led scientific research and policy advocacy. They use this experience to help improve the relevance of HARMONY work for patients. >>> www.bigdataforbloodcancer.eu
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
